The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76

Flegal, 2002, Prevalence and trends in obesity among US adults, 1999–2000, JAMA, 288, 1723, 10.1001/jama.288.14.1723

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States, Hepatology, 40, 1387, 10.1002/hep.20466

Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775

Caldwell, 1999, Cryptogenic cirrhosis, Hepatology, 29, 664, 10.1002/hep.510290347

Powell, 1990, The natural history of nonalcoholic steatohepatitis, Hepatology, 11, 74, 10.1002/hep.1840110114

Teli, 1995, The natural history of nonalcoholic fatty liver, Hepatology, 22, 1714, 10.1002/hep.1840220616

Matteoni, 1999, Nonalcoholic fatty liver disease, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8

Evans, 2002, Non-alcoholic steatohepatitis, J Clin Pathol, 55, 689, 10.1136/jcp.55.9.689

Melton, 1996, History of the Rochester Epidemiology Project, Mayo Clin Proc, 71, 266, 10.4065/71.3.266

Evans, 2001, Profiles of demographic characteristics, 2000 Census of Population and Housing, Minnesota

Caldwell, 2004, The spectrum expanded, J Hepatol, 40, 578, 10.1016/j.jhep.2004.02.013

1999

Brunt, 1999, Nonalcoholic steatohepatitis, Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x

2001, 2000 Minnesota Health Statistics Annual Summary, General Mortality, Minnesota Department of Health

Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N Engl J Med, 339, 229, 10.1056/NEJM199807233390404

Calle, 1999, Body-mass index and mortality in a prospective cohort of U.S. adults, N Engl J Med, 341, 1097, 10.1056/NEJM199910073411501

Saydah, 2003, Abnormal glucose tolerance and the risk of cancer death in the United States, Am J Epidemiol, 157, 1092, 10.1093/aje/kwg100

Knowler, 2002, Diabetes prevention program research group, N Engl J Med, 346, 393

Eriksson, 1998, No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise, Diabetologia, 41, 1010, 10.1007/s001250051024

1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8

Malik, 2004, Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults, Circulation, 110, 1245, 10.1161/01.CIR.0000140677.20606.0E

Hunt, 2004, National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study, Circulation, 110, 1251, 10.1161/01.CIR.0000140762.04598.F9